Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01778439
Title A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco/Helen Diller Cancer Institute San Francisco California 94115 United States Details
University of Colorado Denver -RCI-South Tower Aurora Colorado 80045 United States Details
Karmanos Cancer Institute (KCI) Detroit Michigan 48201 United States Details
Wayne State University/Oncology Karmanos Cancer Institute Detroit Michigan 48201 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field